10 Deals That Shook up the Diagnostics Industry2

Hologic Shines With Gen-Probe M&A
In 2012, Hologic was growing significantly in its diagnostics offerings. But the Marlborough, MA-based company needed a bit more. The firm remedied this situation by making a move to acquire Gen-Probe for $3.7 billion. The acquisition would give the company an edge against competitors and a greater presence in the molecular diagnostics and services market.
 
LabCorp Finds New Opportunities in Clinical Trials With Covance
LabCorp made a significant change to its business back in 2014. The medical diagnostics company moved into the drug research and development with the acquisition of Covance for $6.1 billion. The Covance acquisition diversified the Burlington, NC-based company even further into the clinical trial space. LabCorp made news earlier this week when it announced that its Covance unit would acquire Envigo's non-clinical research services business. In addition, Envigo's Research Models Services business would acquire the Covance Research Products business.
 
Myriad Expands its Horizons in Neurology
Myriad Genetics received its first neuroscience diagnostic through the acquisition of Assurex Health. The GeneSight diagnostic, which was developed by Assurex, is a genetic test for psychotropic medicine selection. Salt Lake City, UT-based Myriad said the market potential for the test could well exceed $4 billion.